Alliance for Pandemic Preparedness

April 13, 2020

COVID-19 and Diabetes: Knowledge in Progress



  • Hussain et al reviewed scientific literature for general characteristics of the SARS-CoV-2 to provide a better understanding and management of COVID-19 in diabetic patients. They identified chronic inflammation, increased coagulation activity, immune response impairment, and potential direct pancreatic damage by SARS-CoV-2 as underlying mechanisms. They caution against using chloroquine during hypoglycemic events in patients. From these limited evidence, no definite conclusions were made. Further research is warranted.

Hussain et al. (April 6 2020). COVID-19 and Diabetes: Knowledge in Progress. Pre-print downloaded April 13 from